Form 8-K - Current report:
SEC Accession No. 0001619856-23-000123
Filing Date
2023-11-07
Accepted
2023-11-07 16:02:22
Documents
14
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20231107.htm   iXBRL 8-K 27749
2 EX-99.1 crbu-20231107xexx991.htm EX-99.1 79172
6 img25401123_0a.jpg GRAPHIC 52289
  Complete submission text file 0001619856-23-000123.txt   323747

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20231107.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20231107_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20231107_pre.xml EX-101.PRE 13587
8 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20231107_htm.xml XML 2916
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 231383569
SIC: 2836 Biological Products, (No Diagnostic Substances)